A Trial of 18-22mg/kg/d Ursodeoxycholic in Refractory Primary Biliary Cholangitis

Condition:   Primary Biliary Cholangitis Interventions:   Drug: 18-22mg/kg/d Ursodeoxycholic;   Drug: 13-15mg/kg/d Ursodeoxycholic Sponsor:   West China Hospital Not yet recruiting

Source: ClinicalTrials.gov - November 17, 2017 Category: Research Source Type: clinical trials